Xylem Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Xylem Inc. on December 11, 2017, regarding events occurring on December 8, 2017. The filing discloses the entry into a Material Definitive Agreement to acquire Pure Technologies Ltd. ("Pure"), a corporation based in Alberta, Canada.
Key Financial Metrics and Transaction Terms
- Transaction Type: Statutory plan of arrangement to acquire all issued and outstanding common shares of Pure.
- Share Consideration: CAD $9.00 per share.
- Enterprise Value: CAD $509 million (approximately USD $397 million).
- Financing: Expected to be funded through cash on hand and debt; the agreement contains no financing condition.
- Termination Fee: CAD $25 million payable by Pure to Xylem under certain termination circumstances.
Material Changes and Conditions
The acquisition is subject to several material conditions, including:
- Expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.
- Approval by Pure's shareholders at a special meeting.
- Receipt of interim and final court orders from the Court of Queen's Bench of Alberta.
- Other customary closing conditions.
Pure is subject to "no-shop" restrictions, though it retains the right to terminate to accept a superior proposal after Xylem has an opportunity to match. Directors and officers of Pure holding approximately 12% of eligible voting securities have entered into support agreements to vote in favor of the transaction.
Outlook, Risks, and Contingencies
The transaction is expected to close by May 31, 2018, under certain circumstances. If the arrangement is not completed by this date, either party may terminate the agreement without a termination fee. The filing includes standard disclaimers that representations and warranties in the agreement are for contractual risk allocation and should not be relied upon as factual characterizations of the companies' current states.
Investor Verification Checklist
- Verify the final exchange rate used to convert the CAD $509 million enterprise value to USD.
- Monitor the status of regulatory approvals, specifically the Hart-Scott-Rodino waiting period and Alberta court orders.
- Track the outcome of the Pure shareholder vote required for approval.
- Review the full Arrangement Agreement (Exhibit 2.1) for detailed covenants and omitted schedules.
- Assess the impact of the acquisition on Xylem's future debt levels and liquidity given the planned use of debt financing.